Olivas A, Ngai P, Schahrer E, Olortegui K, Cursio J, Akiyama S
bioRxiv. 2025; .
PMID: 39974918
PMC: 11838289.
DOI: 10.1101/2025.01.27.635092.
Jin X, You Y, Ruan G, Zhou W, Li J, Li J
Front Med (Lausanne). 2024; 11:1429427.
PMID: 39156693
PMC: 11327023.
DOI: 10.3389/fmed.2024.1429427.
Feakins R, Nunes P, Driessen A, Gordon I, Zidar N, Baldin P
J Crohns Colitis. 2023; 18(2):175-191.
PMID: 37607017
PMC: 10896637.
DOI: 10.1093/ecco-jcc/jjad142.
Suga N, Murakami A, Arimitsu H, Shiogama K, Tanaka S, Ito M
J Clin Biochem Nutr. 2021; 69(1):61-67.
PMID: 34376915
PMC: 8325771.
DOI: 10.3164/jcbn.20-161.
Lang-Schwarz C, Angeloni M, Agaimy A, Atreya R, Becker C, Dregelies T
J Crohns Colitis. 2021; 15(10):1621-1630.
PMID: 33773497
PMC: 8495487.
DOI: 10.1093/ecco-jcc/jjab055.
Maximizing the diagnostic information from biopsies in chronic inflammatory bowel diseases: recommendations from the Erlangen International Consensus Conference on Inflammatory Bowel Diseases and presentation of the IBD-DCA score as a proposal for a....
Lang-Schwarz C, Agaimy A, Atreya R, Becker C, Danese S, Flejou J
Virchows Arch. 2020; 478(3):581-594.
PMID: 33373023
PMC: 7973393.
DOI: 10.1007/s00428-020-02982-7.
Assessment of disease activity in inflammatory bowel diseases: Non-invasive biomarkers and endoscopic scores.
Rodrigues B, Mazzaro M, Nagasako C, Ayrizono M, Fagundes J, Leal R
World J Gastrointest Endosc. 2020; 12(12):504-520.
PMID: 33362904
PMC: 7739141.
DOI: 10.4253/wjge.v12.i12.504.
Fibrostenotic strictures in Crohn's disease.
Yoo J, Holubar S, Rieder F
Intest Res. 2020; 18(4):379-401.
PMID: 32259917
PMC: 7609387.
DOI: 10.5217/ir.2019.09148.
Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis.
Tsuboi R, Matsumoto S, Miyatani H, Mashima H
Intern Med. 2018; 58(5):649-654.
PMID: 30333413
PMC: 6443567.
DOI: 10.2169/internalmedicine.1607-18.
Histologic scoring indices for evaluation of disease activity in ulcerative colitis.
Mosli M, Parker C, Nelson S, Baker K, MacDonald J, Zou G
Cochrane Database Syst Rev. 2017; 5:CD011256.
PMID: 28542712
PMC: 6481362.
DOI: 10.1002/14651858.CD011256.pub2.
The zinc sensing receptor, ZnR/GPR39, triggers metabotropic calcium signalling in colonocytes and regulates occludin recovery in experimental colitis.
Sunuwar L, Medini M, Cohen L, Sekler I, Hershfinkel M
Philos Trans R Soc Lond B Biol Sci. 2016; 371(1700).
PMID: 27377730
PMC: 4938021.
DOI: 10.1098/rstb.2015.0420.
Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa--Pharmaceutical Characterization and Fluorescence Imaging.
Ali H, Weigmann B, Collnot E, Khan S, Windbergs M, Lehr C
Pharm Res. 2016; 33(5):1085-92.
PMID: 26718953
DOI: 10.1007/s11095-015-1852-6.
The histopathological mimics of inflammatory bowel disease: a critical appraisal.
Woodman I, Schofield J, Haboubi N
Tech Coloproctol. 2015; 19(12):717-27.
PMID: 26385573
DOI: 10.1007/s10151-015-1372-8.
Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging.
Rimola J, Planell N, Rodriguez S, Delgado S, Ordas I, Ramirez-Morros A
Am J Gastroenterol. 2015; 110(3):432-40.
PMID: 25623654
DOI: 10.1038/ajg.2014.424.
The histopathological approach to inflammatory bowel disease: a practice guide.
Langner C, Magro F, Driessen A, Ensari A, Mantzaris G, Villanacci V
Virchows Arch. 2014; 464(5):511-27.
PMID: 24487791
DOI: 10.1007/s00428-014-1543-4.
Manganese superoxide dismutase plays an important role in the inflammatory process and predicts disease severity and activity in patients with ulcerative colitis.
Ikumoto T, Hayashi S, Tomita S, Miwa S, Mitomi H, Fujimori T
APMIS. 2014; 122(6):512-7.
PMID: 24483941
PMC: 4226327.
DOI: 10.1111/apm.12192.
Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity?.
Bates J, Diehl L
J Pathol. 2013; 232(2):112-20.
PMID: 24122796
PMC: 4285849.
DOI: 10.1002/path.4277.
A novel approach for quantitative assessment of mucosal damage in inflammatory bowel disease.
Matalka I, Al-Omari F, Salama R, Mohtaseb A
Diagn Pathol. 2013; 8:156.
PMID: 24053788
PMC: 3852335.
DOI: 10.1186/1746-1596-8-156.
Hsp10, Hsp70, and Hsp90 immunohistochemical levels change in ulcerative colitis after therapy.
Tomasello G, Sciume C, Rappa F, Rodolico V, Zerilli M, Martorana A
Eur J Histochem. 2012; 55(4):e38.
PMID: 22297444
PMC: 3284240.
DOI: 10.4081/ejh.2011.e38.